Get the Stockscreener App
56.60
1.13%
0.63
After Hours:
57.00
0.40
+0.71%
Globus Medical Inc stock is traded at $56.60, with a volume of 2.42M.
It is up +1.13% in the last 24 hours and down -5.54% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$55.97
Open:
$56.14
24h Volume:
2.42M
Relative Volume:
1.69
Market Cap:
$8.32B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
42.24
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
-5.98%
1M Performance:
-5.54%
6M Performance:
-34.60%
1Y Performance:
-17.49%
1-Day Range:
$56.11
$57.04
1-Week Range:
$55.84
$60.97
52-Week Range:
$54.48
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
56.60 | 8.32B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
133.36 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.41 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
389.50 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.58 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.39 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
August 15th Options Now Available For Globus Medical (GMED) - Nasdaq
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.GMED - PR Newswire
Globus Medical Announces $500M Share Repurchase Program to Boost Shareholder Value - MSN
Is Globus Medical, Inc.'s (NYSE:GMED) Recent Price Movement Underpinned By Its Weak Fundamentals? - simplywall.st
Globus Medical’s SWOT analysis: robotic spine leader’s stock poised for growth By Investing.com - Investing.com South Africa
Globus Medical’s SWOT analysis: robotic spine leader’s stock poised for growth - Investing.com
Medical Devices & SuppliesSpecialty Stocks Q1 Recap: Benchmarking Globus Medical (NYSE:GMED) - Yahoo Finance
Globus Medical, Inc. (NYSE:GMED) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Globus Medical (GMED) Poised for Growth Despite Recent Challenge - GuruFocus
Globus Medical (GMED) Poised for Growth Despite Recent Challenges | GMED Stock News - GuruFocus
Parallel Advisors LLC Purchases 193 Shares of Globus Medical, Inc. (NYSE:GMED) - Defense World
Total Disc Replacement Market Detailed in New Report - openPR.com
GAMMA Investing LLC Raises Position in Globus Medical, Inc. (NYSE:GMED) - Defense World
Collegeville Office Buildings Sell to Globus Medical with Staggering Price Cut - VISTA.Today
Globus Medical Approves Key Proposals at Annual Meeting - TipRanks
Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential - Yahoo Finance
Adult Spinal Deformity Market Detailed in New Research Report - openPR.com
Globus Medical Inc (GMED) Stock Price, Trades & News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED - FinancialContent
Zacks Research Predicts Lower Earnings for Globus Medical - Defense World
Collegeville office buildings sell for 81% less than previous sale price - The Business Journals
Globus Medical announces share buyback program of up to $500M - MSN
Globus Medical’s $250M Nevro Bet: Can This Bold Acquisition Disrupt Neuromodulation? - Smartkarma
BTIG Downgrades Globus Medical (BMV:GMED) - Nasdaq
BTIG cuts Globus Medical stock rating to neutral, removes PT By Investing.com - Investing.com Canada
BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns - Insider Monkey
Globus Medical (GMED): JMP Securities Reiterates Market Perform Rating | GMED Stock News - GuruFocus
Analysts downgrade Globus Medical on fears of ‘foundational cracks’ - MassDevice
Globus Medical (GMED) Downgraded by BTIG to Neutral | GMED Stock News - GuruFocus
This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - Benzinga
Assessing Globus Medical: Insights From 4 Financial Analysts - Benzinga
BTIG Downgrades Globus Medical to Neutral From Buy - marketscreener.com
Future STEM Leaders: Chester County Futures Students Explore Careers at Globus Medical - VISTA.Today
Globus Medical (GMED) Downgraded by BTIG Over Spine Business Con - GuruFocus
JMP maintains Market Perform on Globus Medical stock By Investing.com - Investing.com India
JMP maintains Market Perform on Globus Medical stock - Investing.com
Globus Medical, Inc. (NYSE:GMED) Stock Holdings Lifted by Cetera Investment Advisers - Defense World
Globus Medical’s SWOT analysis: spine leader faces headwinds, eyes robotics growth - Investing.com Canada
ATTENTION Globus Medical, Inc. (GMED) Investors: Possible FraudContact Levi & Korsinsky Today - Louisiana First News
Globus Medical’s Q1:2025 Op Profit Soars - Orthopedics This Week
Deutsche Bank AG Acquires 1,157 Shares of Globus Medical, Inc. (NYSE:GMED) - Defense World
Spinal Implants and Surgery Devices Market Is Booming So Rapidly with Zimmer Biomet, Globus Medical - openPR.com
Globus Medical And 2 Other Growth Companies Insiders Are Betting On - Yahoo Finance
Ameriprise Financial Inc. Grows Position in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):